However, investigations into IL-33 genetic polymorphisms and serum levels among breast cancer patients and healthy individuals have found no significant differences in the frequencies of genotypes and alleles at specific single nucleotide polymorphisms (SNPs) in the IL-33 gene. Here, IL33 is linked to breast carcinoma.